Log In
BCIQ
Print this Print this
 

Alair System

  Manage Alerts
Collapse Summary General Information
Company Boston Scientific Corp.
DescriptionSystem delivering bronchial thermoplasty to targeted airways
Molecular Target Not applicable
Mechanism of Action 
Therapeutic ModalityMedical Devices
Latest Stage of DevelopmentMarketed
Standard IndicationAsthma
Indication DetailsTreat severe and persistent asthma not well-controlled with inhaled corticosteroids and long-acting beta agonist (LABA) medications
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$443.5M

$193.5M

$250.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/27/2010

$443.5M

$193.5M

$250.0M

Get a free BioCentury trial today